Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2792  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
  »  Article in PDF (111 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  References
 »  Article Figures

 Article Access Statistics
    Viewed5375    
    Printed84    
    Emailed0    
    PDF Downloaded1004    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
LETTER TO EDITOR
Year : 2007  |  Volume : 55  |  Issue : 1  |  Page : 89-90

Coexistence of Wilson's disease and neurofibromatosis type 1 in a 14-year-old boy


Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Date of Acceptance01-Aug-2006

Correspondence Address:
Seyed Mohammad Hassan Paknejad
Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.30446

Rights and Permissions



How to cite this article:
Sahraian MA, Motamedi M, Paknejad SH, Azimi AR. Coexistence of Wilson's disease and neurofibromatosis type 1 in a 14-year-old boy. Neurol India 2007;55:89-90

How to cite this URL:
Sahraian MA, Motamedi M, Paknejad SH, Azimi AR. Coexistence of Wilson's disease and neurofibromatosis type 1 in a 14-year-old boy. Neurol India [serial online] 2007 [cited 2021 Sep 25];55:89-90. Available from: https://www.neurologyindia.com/text.asp?2007/55/1/89/30446


Sir,

We herein report a 14-year-old boy admitted to our hospital, with a single episode of secondary generalized tonic-clonic convulsion. He had history of mild learning difficulty at school from two years prior to admission [Figure - 1].

On physical examination, we found more than 12 cafι-au-lait spots (most > 2 cm), re-established with dermatologic consultation using biopsy, over the body and axillary freckling, without any plexifiorm neuroma or neurofibroma, which raised the possibility of neurofibromatosis Type 1 (NF1).

Routine blood tests were normal and brain magnetic resonance imaging (MRI) showed signal changes in basal ganglia and cerebral cortex with hydrocephaly.

He developed bradykinesia, cogwheel rigidity and mental impairment during follow-up treating with carbamazepin and reevaluated with impression of young onset  Parkinsonism More Details. Another precise physical examination showed KF rings and lab tests were all compatible with WD [marked decreased serum ceruloplasmin and copper, increased urinary copper].

The patient was started on Trientine and zinc sulfate and we discontinued trientine after eight weeks.

This patient presented with cafι-au-lait spots and axillary freckling. According to clinical criteria,[1] he fulfilled the criteria of NF1, but had no positive family history. During follow-up, Parkinsonism had added to the patient's problems, a finding that is not compatible with NF1.

Although it is advised to explain all the signs and symptoms with one disease, there are instances in which another concomitant disease should be considered.

The most common features of NF1 are pigmentary abnormalities, such as macules, skin folds freckling and iris hamartomas (Lisch Nodules).

They are prone to the development of a wide variety of nervous system abnormalities like benign and malignant tumors of the peripheral and central nervous systems.[2]

Diagnosis of NF1 is based on clinical criteria,[3],[4] although genetic study can be used for finding the mutations.

This case may be interesting with having two different genetic diseases with diverse neurological complications, although estimating statistically, this may be the only case in the world, but it is possible that perhaps 60 other similar examples exist.

Two different genetic diseases may be present at the same time and during practice, we should avoid early closure of diagnosis. This may result from premature fixation on some items in the history or examination.

The first diagnostic consideration should be rearranged to modification when new items of information are secured.

 
 » References Top

1.MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D, et al . Diagnostic criteria for chwannomatosis. Neurology 2005;64:1838-45.  Back to cited text no. 1    
2.Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004;17:101-5.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Reynolds RM, Browning GG, Nawroz I, Campbell IW. Von Recklinghausen's neurofibromatosis: Neurofibromatosis type 1. Lancet 2003;361:1552-4.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Friedman JM, Birch PH. Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997;70:138-43.  Back to cited text no. 4    


    Figures

[Figure - 1]

This article has been cited by
1 Association of Wilsonęs disease with neurofibromatosis [AsociaciĆ³n de la enfermedad de Wilson con neurofibromatosis]
Sawamura, R. and Brunaldi, M.O. and Ramalho, L.N.Z. and Zucoloto, S. and Balancin, M.L. and Fernandes, M.I.M.
Revista Espanola de Enfermedades Digestivas. 2011; 103(10): 551-553
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow